Statistics for Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy
Total visits
views | |
---|---|
Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy | 236 |
Total visits per month
views | |
---|---|
January 2024 | 0 |
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 1 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
File Visits
views | |
---|---|
Paraskar_2010_harnessing.pdf | 148 |
Top country views
views | |
---|---|
United States | 165 |
Germany | 12 |
Ukraine | 8 |
China | 6 |
Sweden | 6 |
United Kingdom | 4 |
Russia | 3 |
France | 2 |
Canada | 1 |
Czechia | 1 |
Egypt | 1 |
Malaysia | 1 |
Pakistan | 1 |
Romania | 1 |
Top city views
views | |
---|---|
Wilmington | 57 |
Fairfield | 19 |
Ann Arbor | 9 |
Houston | 9 |
White Plains | 9 |
Kiev | 8 |
Kiez | 8 |
Washington | 7 |
Jacksonville | 6 |
Lake Mary | 6 |
Cambridge | 5 |
San Francisco | 5 |
Stockholm | 5 |
Beijing | 3 |
Saint Petersburg | 3 |
Shenzhen | 3 |
Concord | 2 |
Gunzenhausen | 2 |
Nanterre | 2 |
Nürnberg | 2 |
Ashburn | 1 |
Augusta | 1 |
Baltimore | 1 |
Brooklyn | 1 |
Chicago | 1 |
Indianapolis | 1 |
Islamabad | 1 |
Kafr ash Shaykh Hilal | 1 |
Motala | 1 |
Norwalk | 1 |
Philadelphia | 1 |
Scottsdale | 1 |
Seattle | 1 |
Seremban | 1 |
Slapanice | 1 |
Toronto | 1 |
Whiteland | 1 |